Cordani David's Form 4 filing
Cigna Group (CI) · filed Mar 5, 2024
- Accession no.
- 0001225208-24-003707
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.42M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cordani DavidCIK 0001318751 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock, $.01 Par Value | AGrant or awardAcquired | +35,946 | $0.00 | $0 | 382,656 | Direct | |
| Mar 1, 2024 | Common Stock, $.01 Par Value | FTax withholdingDisposed | −6,272 | $333.36 | −$2,090,833.92 | 376,384 | Direct | |
| Mar 1, 2024 | Common Stock, $.01 Par Value | FTax withholdingDisposed | −16,658 | $333.36 | −$5,553,110.88 | 359,726 | Direct | |
| Mar 4, 2024 | Common Stock, $.01 Par Value | SSaleDisposed | −19,288 | $332.62 | −$6,415,574.56 | 340,438 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.